sellWeak cluster of 310b5-1 plan
Malik Fady Ibraham sold $379k of CYTK
EVP Research & Development at CYTOKINETICS INC. 7,300 shares at an average of $51.91, traded Oct 30, 2024, filed Oct 31, 2024.
Warning score
11Value
$379k
7,300 shares
Holdings after
114,920
-6% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001127602-24-026160, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 30, 2024 | MOption exercise Common Stock10b5-1 | +5,300 | $7.96 | $42k | 122,220 | Oct 31, 2024 |
| Oct 30, 2024 | SOpen-market sale Common Stock10b5-1 | -5,300 | $51.90 | $275k | 116,920 | Oct 31, 2024 |
| Oct 30, 2024 | SOpen-market sale Common Stock10b5-1 | -2,000 | $51.93 | $104k | 114,920 | Oct 31, 2024 |
| Oct 30, 2024 | MOption exercise Non-Qualified Stock Option (Right to Buy)derivative10b5-1 | -5,300 | $0.00 | $0 | 15,900 | Oct 31, 2024 |
Related signals
Other insiders at CYTOKINETICS INC and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 1Weak | sell 410b5-1 | CYTK CYTOKINETICS INC | WIERENGA WENDALL director | $36k | 742 | |
| 4Weak | sell 410b5-1 | CYTK CYTOKINETICS INC | HENDERSON JOHN T director | $90k | 1,780 | |
| 10Weak | sell 410b5-1 | CYTK CYTOKINETICS INC | Malik Fady Ibraham EVP Research & Development | $370k | 7,300 | |
| 18Weak | sell 410b5-1 | CYTK CYTOKINETICS INC | Blum Robert I President & CEO | $254k | 5,000 | |
| 1Weak | sell 310b5-1 | CYTK CYTOKINETICS INC | WIERENGA WENDALL director | $37k | 742 | |
| 10Weak | sell 310b5-1 | CYTK CYTOKINETICS INC | Malik Fady Ibraham EVP Research & Development | $366k | 7,300 | |
| 18Weak | sell 310b5-1 | CYTK CYTOKINETICS INC | Blum Robert I President & CEO | $253k | 5,000 | |
| 10Weak | sell 310b5-1 | CYTK CYTOKINETICS INC | Malik Fady Ibraham EVP Research & Development | $371k | 6,342 | |
| 18Weak | sell 310b5-1 | CYTK CYTOKINETICS INC | Blum Robert I President & CEO | $258k | 5,000 | |
| 13Weak | sell 310b5-1 | CYTK CYTOKINETICS INC | WIERENGA WENDALL director | $233k | 4,452 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.